The Rebar Straightening Machine India, these are the hot sales,

India suppliers can’t produce these kinds rebar straightening machines, all of them import these machines from China, from us directly or through a trader company.

They sell them on B2B platform and store distributors, prices are different in Rupees

In these cities you can buy the machines convenient,

Mumbai,Delhi,Bangalore,Hyderabad,Ahmedabad,Chennai,Kolkata,Surat,Pune,Jaipur,Lucknow,Kanpur,Nagpur,Visakhapatnam,Indore,Thane,Bhopal,Pimpri-Chinchwad,Patna,Vadodara,Ghaziabad,Ludhiana,Coimbatore,Agra,Madurai

Overview India (Quoted from Wikipedia)

India,also known as the Republic of India, is a country in South Asia. It is the seventh-largest country by area, the second-most populous country (with over 1.2 billion people), and the most populous democracy in the world. Bounded by the Indian Ocean on the south, the Arabian Sea on the southwest, and the Bay of Bengal on the southeast, it shares land borders with Pakistan to the west;[f] China, Nepal, and Bhutan to the northeast; and Bangladesh and Myanmar to the east. In the Indian Ocean, India is in the vicinity of Sri Lanka and the Maldives, while its Andaman and Nicobar Islands share a maritime border with Thailand and Indonesia.

Economy of Industry

India’s telecommunication industry, the world’s fastest-growing, added 227 million subscribers during the period 2010–11, and after the third quarter of 2017, India surpassed the US to become the second largest smartphone market in the world after China.

The Indian automotive industry, the world’s second-fastest growing, increased domestic sales by 26% during 2009–10, and exports by 36% during 2008–09. India’s capacity to generate electrical power is 300 gigawatts, of which 42 gigawatts is renewable. At the end of 2011, the Indian IT industry employed 2.8 million professionals, generated revenues close to US$100 billion equalling 7.5% of Indian GDP and contributed 26% of India’s merchandise exports.

The pharmaceutical industry in India is among the significant emerging markets for the global pharmaceutical industry. The Indian pharmaceutical market is expected to reach $48.5 billion by 2020. India’s R & D spending constitutes 60% of the biopharmaceutical industry. India is among the top 12 biotech destinations in the world.The Indian biotech industry grew by 15.1% in 2012–13, increasing its revenues from 204.4 billion INR (Indian rupees) to 235.24 billion INR (3.94 B US$ – exchange rate June 2013: 1 US$ approx. 60 INR).